Bifogade filer
Q4 Interim Report 2025 Final
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
Magle Group’s Q4 report highlights restructuring measures, portfolio clean-up and a focus on improving profitability in a challenging financial environment.
Q4 2025 KEY INDICATORS
- Net Sales amounted to 77.7 MSEK (87.2)
- EBITDA equaled -58.5 MSEK (20.0)
- Operating profit (EBIT) is -120.3 MSEK (3.9)
- Earnings per share SEK -6.49 (-0.04) per share
JAN-DEC 2025 KEY INDICATORS
- Net Sales amounted to 282.9 MSEK (236.0)
- EBITDA equaled -26.5 MSEK (58.9)
- Operating profit (EBIT) is -126.7 MSEK (23.2)
- Earnings per share SEK -7.74 (0.93) per share
“Our priority is to sharpen the Group’s business focus and improve profitability by directing resources towards the parts of the business where we see the strongest commercial traction and most predictable returns. The adjustments made during the quarter form part of an ongoing clean-up of the portfolio and cost structure, aimed at reducing complexity and improving capital efficiency. While these measures impact the short-term financial outcome, they are necessary steps in building a more focused and financially sustainable organisation.”